BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Repertoire Immune Medicines

1 post

Repertoire Immune Medicines is a clinical-stage biotechnology firm developing medicines that unlock and utilize the massive potential of the human immune system to prevent or treat cancer, as well as autoimmune and viral diseases.

Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery T Cell Receptors

Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

  • BioTech Health X
  • April 29, 2021
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 89bio (ETNB) is on Every Analyst’s Watchlist
  • 60 Degrees Pharmaceuticals (XTP) Could Be the Next $10 Biotech
  • 4D Molecular Therapeutics (FDMT) Could Be the Next $5 Billion Gene Therapy Titan
  • Firefly Neuroscience (AIFF) Skyrockets 483%
  • Organogenesis (ORGO): The $3 Stock Disrupting Wound Healing & Regenerative Medicine
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 15, 2025
    89bio (ETNB) is on Every Analyst’s Watchlist
    • June 15, 2025
    60 Degrees Pharmaceuticals (XTP) Could Be the Next $10 Biotech
    • June 15, 2025
    4D Molecular Therapeutics (FDMT) Could Be the Next $5 Billion Gene Therapy Titan
    • June 15, 2025
    Firefly Neuroscience (AIFF) Skyrockets 483%
    • June 15, 2025
    Organogenesis (ORGO): The $3 Stock Disrupting Wound Healing & Regenerative Medicine
Recent Posts
  • PepGen (PEPG) s Poised to Disrupt Rare Disease Therapy
    • June 15, 2025
  • Enveric Biosciences (ENVB) Just Might Be the Most Undervalued Biotech in Mental Health
    • June 15, 2025
  • Cumberland Pharma (CPIX) is Beating Big Pharma at Its Own Game
    • June 15, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (183)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top